Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
110M
-
Shares change
-
+7.65M
-
Total reported value, excl. options
-
$2.41B
-
Value change
-
+$173M
-
Put/Call ratio
-
0.52
-
Number of buys
-
110
-
Number of sells
-
-72
-
Price
-
$22.03
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q4 2024
220 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q4 2024.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110M shares
of 240M outstanding shares and own 45.6% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.9M shares), FMR LLC (10.6M shares), AXON ENTERPRISE, INC. (9M shares), MORGAN STANLEY (5.16M shares), ACADIAN ASSET MANAGEMENT LLC (4.76M shares), Nine Ten Capital Management LLC (3.61M shares), Clal Insurance Enterprises Holdings Ltd (3.5M shares), Voss Capital, LP (3.24M shares), CROSSLINK CAPITAL INC (3.02M shares), and Pertento Partners LLP (2.98M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.